☰

Richard A. Beswick, Ph.D. - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Neuroscience
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Jin L, Beswick RA, Yamamoto T, Palmer T, Taylor TA, Pollock JS, Pollock DM, Brands MW, Webb RC. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats. Journal of Physiology and Pharmacology : An Official Journal of the Polish Physiological Society. 57: 343-57. PMID 17033089  0.582
2001 Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 38: 1107-11. PMID 11711506 DOI: 10.1161/Hy1101.093423  0.555
2001 Hill WD, Hess DC, Carroll JE, Wakade CG, Howard EF, Chen Q, Cheng C, Martin-Studdard A, Waller JL, Beswick RA. The NF-kappaB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia. Brain Research Bulletin. 55: 375-86. PMID 11489345 DOI: 10.1016/S0361-9230(01)00503-2  0.3
2001 Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension. 37: 781-6. PMID 11230373 DOI: 10.1161/01.Hyp.37.2.781  0.581
2000 Beswick RA, Dorrance AN, Rajagopalan S, Webb RC. Nf-Kb Inhibition Lowers Blood Pressure in Mineralocorticoid Hypertensive Rats. Hypertension. 36: 692-692. DOI: 10.1161/01.Hyp.36.Suppl_1.692  0.634
Show low-probability matches.